Avanos Medical Inc. (AVNS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
11.79
0.46 (4.06%)
At close: Oct 03, 2025, 3:59 PM
11.79
0.00%
After-hours: Oct 03, 2025, 05:30 PM EDT

Avanos Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
175M 167.5M 179.6M 170.4M 171.7M 166.1M 173.3M 171.3M 169.4M 159.3M 181.6M 172.3M 170.9M 197.4M 193.4M 184.1M 186.4M 180.7M
Cost of Revenue
82.9M 77.7M 80.3M 77.5M 76.1M 71.3M 78.3M 75.8M 71.6M 67.9M 78.7M 72.1M 69.3M 90.8M 95.6M 92.1M 94.9M 88.2M
Gross Profit
92.1M 89.8M 99.3M 92.9M 95.6M 94.8M 95M 95.5M 97.8M 91.4M 102.9M 100.2M 101.6M 106.6M 97.8M 92M 91.5M 92.5M
Operating Income
7.3M 7.3M 12.5M 16.7M 16.1M 7.4M 22.2M 25.5M 11.8M 5.5M 17.4M 15M 11.8M 13.1M 19.2M 11.7M 15.2M 11.1M
Interest Income
600K 1.5M 800K 700K 3M 600K 1M 900K 500K 500K 700K 300K 200K n/a n/a 200K n/a n/a
Pretax Income
-75.9M 9.7M -420.5M 9.5M 6.2M 1.5M 8.9M -2.6M -5.1M -9.1M 14.3M 10.1M 7.6M 7.3M 24.3M 2.9M -8.2M -13.2M
Net Income
-76.8M 6.6M -397.3M 4.3M 1.8M -900K 10.5M -3.7M -68.1M -500K 16.9M 15.7M 12.5M 5.4M 10M -35.1M 37.9M -7.6M
Selling & General & Admin
79M 77.1M 81.1M 69M 73.2M 80.4M 66M 63.9M 79.2M 78.4M 78.3M 78.1M 82.2M 85.7M 71M 71.9M 68.3M 73.1M
Research & Development
5.8M 5.4M 5.7M 7.2M 6.3M 7M 6.8M 6.1M 6.8M 7.9M 7.5M 7.3M 8M 7.8M 7.6M 8.4M 8M 8.3M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
84.8M 82.5M 86.8M 76.2M 79.5M 87.4M 72.8M 70M 86M 85.9M 85.5M 85.2M 89.8M 93.5M 78.6M 80.3M 76.3M 81.4M
Interest Expense
2M 2.1M 2.8M 3.2M 3.1M 3.1M 3.3M 4.7M 3.5M 3.5M 3M 3M 2.7M 1.3M 700K 900K 900K 800K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
167.7M 160.2M 167.1M 153.7M 155.6M 158.7M 151.1M 145.8M 157.6M 153.8M 164.2M 157.3M 159.1M 184.3M 174.2M 172.4M 171.2M 169.6M
Income Tax Expense
900K 3.1M -23.5M 3.6M 1.9M 1M -2.1M 6.2M -800K -1.3M 4.6M -900K 2.8M 1.9M 14.3M 38M -46.1M -5.6M
Shares Outstanding (Basic)
46.1M 46.1M 46M 46M 45.9M 46.2M 46.2M 46.8M 46.8M 46.6M 46.5M 46.6M 47.2M 47.4M 48.2M 48.1M 48.1M 47.5M
Shares Outstanding (Diluted)
46.8M 46.8M 46M 46.6M 46.3M 46.2M 46.6M 46.8M 46.8M 46.6M 47M 47M 47.6M 47.8M 48.6M 48.1M 48.6M 48M
EPS (Basic)
-1.66 0.14 -8.64 0.09 0.04 -0.02 0.23 -0.08 -1.46 -0.01 0.36 0.34 0.24 0.12 0.21 -0.73 0.79 -0.16
EPS (Diluted)
-1.66 0.14 -8.64 0.09 0.04 -0.02 0.23 -0.08 -1.46 -0.01 0.36 0.33 0.24 0.12 0.21 -0.73 0.78 -0.16
EBITDA
-63.9M 21.4M -406.6M 24.4M 20.6M 16M 23.7M 13.1M 8.7M 5.1M 28.7M 23.1M 20.4M 19.7M 34.5M 13.4M 2.2M -2.7M
EBIT
-73.9M 11.8M -417.7M 12.7M 9.3M 4.6M 12.2M 2.1M -1.6M -5.6M 17.3M 13.1M 10.3M 8.6M 25M 3.8M -7.3M -12.4M
Depreciation & Amortization
10M 9.6M 11.1M 11.7M 11.3M 11.4M 11.5M 11M 10.3M 10.7M 11.4M 10M 10.1M 11.1M 9.5M 9.6M 9.5M 9.7M